Endoscopic ultrasound‐guided gastrointestinal anastomosis: Current status and future perspectives

Objectives Both clinical experience and supporting data have improved drastically in the context of endoscopic ultrasound‐guided gastrointestinal anastomosis (EUS‐GIA). Where outcomes used to be questioned, focus has now moved towards performing comparative studies, optimizing technical approaches, improving patient selection, and developing well‐defined treatment algorithms. Methods The purpose of this review is to provide an overview of technical developments within EUS‐GIA and to discuss the current status of EUS‐GIA and future directions. Results EUS‐GIA techniques such as EUS‐guided gastroenterostomy (EUS‐GE), EUS‐directed transgastric endoscopic retrograde cholangiopancreatography (ERCP) (EDGE) and EUS‐guided treatment afferent loop syndrome have undergone further development, refining technical approaches, improving patient selection and subsequent outcomes. Retrospective evaluations of EUS‐GE have shown similar safety when compared to enteral stenting, whilst attaining surgical range efficacy. Whereas, in patients with gastric bypass anatomy, EDGE seems less cumbersome and time consuming than enteroscopy‐assisted ERCP, while preventing surgical morbidity associated with laparoscopy‐assisted ERCP. Although less evidence is available on EUS‐guided treatment of afferent loop syndrome, this technique has been associated with higher clinical success and fewer reinterventions and adverse events when compared to enteral stenting and percutaneous drainage, respectively. Several randomized studies are currently underway evaluating EUS‐GE in malignant gastric outlet obstruction (GOO), whereas more prospective data are still required on EDGE and long‐term fistula management. Conclusion EUS‐GIA has become a crucial alternative to established techniques, overcoming technical limitations and subsequently improving patient outcomes. Although we should focus on prospective confirmation of these results in the context of GOO and EDGE, the current evidence already allows for a prominent role for EUS‐GIA in our everyday practice.